Sign In
Buy LLY
$1,125.38
+42.15 (+3.89%)
At Close: Jun 04, 2026
Down 15%, Should You Buy the Dip on Eli Lilly?
11:00am, Monday, 27'th Oct 2025
Eli Lilly is one of the largest drug companies in the world. The pharmaceutical giant's stock price is 15% below its 2024 high-water mark.
Buy, Sell or Hold Lilly Stock? Key Tips Ahead of Q3 Earnings
10:56am, Monday, 27'th Oct 2025
Eli Lilly's Q3 results hinge on strong demand for Mounjaro and Zepbound as investors weigh growth drivers against the pressure of pricing and competition.
Seeking Clues to Lilly (LLY) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics
10:17am, Monday, 27'th Oct 2025
Besides Wall Street's top-and-bottom-line estimates for Lilly (LLY), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarte
LLY Stock To $1,100?
09:25am, Monday, 27'th Oct 2025
Eli Lilly (LLY) shares have surged by 16% over the last month and are currently priced at $825. U.S. pharmaceutical stocks have done well of late, as large drugmakers such as Pfizer and AstraZeneca si
Should You Buy Eli Lilly Stock Before Oct. 30?
07:31am, Monday, 27'th Oct 2025
Wall Street expects good news when Lilly announces its Q3 results on Oct. 30. Lilly's stock might not perform as you think it will, even if it beats analysts' estimates.
Phase 3b LUCENT-URGE is the first study in inflammatory bowel disease to assess bowel urgency across three measures — severity, frequency and stool deferral time — reflecting the spectrum of its b
Eli Lilly: Is Another Monster Quarter Coming
08:15am, Sunday, 26'th Oct 2025
October 30th is the day when Eli Lilly will report its third-quarter results, including sales of its 'superstars' Zepbound and Mounjaro. Since my article was published on September 8, Eli Lilly's stoc
Wall Street Week Ahead
07:01am, Sunday, 26'th Oct 2025
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.
Pharmaceutical Stocks To Watch Now – October 24th
02:40am, Sunday, 26'th Oct 2025
Eli Lilly and Company, Wellgistics Health, Pfizer, AbbVie, and Gilead Sciences are the five Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks a
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of A
Here's How Eli Lilly's Oncology Drugs Are Poised Ahead of Q3 Earnings
10:31am, Friday, 24'th Oct 2025
LLY's oncology portfolio, led by Verzenio, is set for double-digit growth as investors eye Q3 results beyond its obesity drugs.
Eli Lilly to buy gene therapy developer Adverum in about $262 million deal
10:11am, Friday, 24'th Oct 2025
Eli Lilly said on Friday it would acquire gene therapy developer Adverum Biotechnologies in a deal valued at up to $261.7 million, aiming to strengthen its pipeline with an experimental eye disease tr
Lilly to Acquire Adverum Biotechnologies
08:30am, Friday, 24'th Oct 2025
Adverum's lead program, Ixo-vec, is a Phase 3 gene therapy designed to treat vision loss associated with wet age-related macular degeneration with a single intravitreal dose Acquisition aligns Lilly
Mounjaro Maker Eli Lilly Jumps In Quality Despite Trump-Fueled Price Cut Fears
08:23am, Friday, 24'th Oct 2025
Eli Lilly and Co. (NYSE:LLY) has surged into the top decile of quality rankings among S&P 500 peers, achieving a percentile score of 90.25 on the latest composite quality report, despite fresh uncerta
Eli Lilly reports promising data for alopecia and eczema drugs, eyes label expansion
06:46am, Friday, 24'th Oct 2025
Eli Lilly announced on Friday safety and efficacy results from two separate late-stage studies testing its approved drugs for alopecia and eczema.
